Olema Pharmaceuticals OLMA
$7.02 −$0.13 (-1.82%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $7.02 0.00%
Open$7.01
Prev close$7.15
Day range$6.88 – $7.36
Volume1.26M
Market cap$615.00M
P/E (TTM)–
Dividend yield–
OLMA Stock News
Headlines matching Olema Oncology or the OLMA ticker, most recent first.
- H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $36
- LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $16 Negative
- Stifel Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $30 Negative
- A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $16 to $59
- Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $59
- Piper Sandler Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $40
- J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $46
- J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Announces Target Price $46
- J.P. Morgan Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating
- A Quick Look at Today's Ratings for Olema Pharmaceuticals(OLMA.US), With a Forecast Between $20 to $59
- LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $24
- H.C. Wainwright Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $38
- LifeSci Capital Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $24 Negative
- Guggenheim Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Cuts Target Price to $35 Negative
- Citi Maintains Olema Pharmaceuticals(OLMA.US) With Buy Rating, Maintains Target Price $62
No comments yet — be the first to weigh in on OLMA.
Sign in to join the discussion.